Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 4/2006

01.08.2006 | Original Paper

Validation of a comprehensive classification tool for treatment-related problems

verfasst von: Salah M. AbuRuz, Nailya R. Bulatova, Almoatasem M. Yousef

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 4/2006

Einloggen, um Zugang zu erhalten

Abstract

Objective

Several drug-related problem classification systems can be found in the literature. However, it is generally agreed that a comprehensive, well constructed and validated instrument is currently lacking. The aim of this study is the development and validation of a comprehensive treatment-related problems assessment and classification tool for use in teaching, practicing and researching pharmaceutical care and to improve identification, resolving and preventing of treatment-related problems.

Method

The development and validation involved five steps starting with literature search to define a treatment related problem and also to form a database of treatment-related problems identified in the literature. In the next step, all problems that were identified in the first step and passed the evaluation of the three authors were pooled together and then divided into groups according to their common or shared construct, in the third step a suitable assessment method was developed according to the construct of the different problems, in the next step the developed instrument was validated for content, internal and external validity. Finally the tool was finalized and tested for reproducibility and inter-rater agreement.

Results

The final validated version included six main categories for treatment-related problems (Indication, Effectiveness, Safety, Knowledge, Adherence and Miscellaneous). These categories include a total of nine subcategories and a total of 29 treatment related problems.

Conclusion

The treatment-related problems assessment and classification tool introduced in this paper was applied to actual patient cases and proved to be valid. This tool also has several features that are new.
Literatur
1.
Zurück zum Zitat Hepler CD, Srand LM. Opportunities and responsibilities in Pharmaceutical Care. Am J Hosp Pharm 1990;47:533–43.PubMed Hepler CD, Srand LM. Opportunities and responsibilities in Pharmaceutical Care. Am J Hosp Pharm 1990;47:533–43.PubMed
2.
Zurück zum Zitat ASHP guidelines on a standardized method for pharmaceutical care. Am J Health Syst Pharm 1996;53:1713–6. ASHP guidelines on a standardized method for pharmaceutical care. Am J Health Syst Pharm 1996;53:1713–6.
3.
Zurück zum Zitat American Society of Hospital Pharmacists. ASHP statement on pharmaceutical care. Am J Hosp Pharm 1993;50:1720–3. American Society of Hospital Pharmacists. ASHP statement on pharmaceutical care. Am J Hosp Pharm 1993;50:1720–3.
4.
Zurück zum Zitat National Academy of Sciences Institute of Medicine. To err is human. Washington, DC: National Academy Press; 1999. National Academy of Sciences Institute of Medicine. To err is human. Washington, DC: National Academy Press; 1999.
5.
Zurück zum Zitat Prince BS, Goetz CM, Rihn TL, Olsky M. Drug-related emergency department visits and hospital admissions. J Am Hosp Pharm 1992;49:1696–700. Prince BS, Goetz CM, Rihn TL, Olsky M. Drug-related emergency department visits and hospital admissions. J Am Hosp Pharm 1992;49:1696–700.
6.
Zurück zum Zitat Hallas J, Gram LF, Grodum E. Drug-related admissions to medical wards: a population based survey. Br J Clin Phamacol 1992;33:61–8. Hallas J, Gram LF, Grodum E. Drug-related admissions to medical wards: a population based survey. Br J Clin Phamacol 1992;33:61–8.
7.
Zurück zum Zitat Pirmohamed M, Breckenridge M, Kitteringham NR, Park BK. Adverse drug reactions. Br Med J 1998;316:1295–8. Pirmohamed M, Breckenridge M, Kitteringham NR, Park BK. Adverse drug reactions. Br Med J 1998;316:1295–8.
8.
Zurück zum Zitat Schneider PJ, Gift M. Cost of medication errors. Int Pharm J 1996;10:S1–11. Schneider PJ, Gift M. Cost of medication errors. Int Pharm J 1996;10:S1–11.
9.
Zurück zum Zitat Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993;27:832–40.PubMed Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993;27:832–40.PubMed
10.
Zurück zum Zitat Neville RG, Robertson F, Livingstone S, Crombie IK. A classification of prescription errors. J Roy Coll Gen Pract 1989;39:110–2 Neville RG, Robertson F, Livingstone S, Crombie IK. A classification of prescription errors. J Roy Coll Gen Pract 1989;39:110–2
11.
Zurück zum Zitat Zermansky A. Who controls repeats? Br J Gen Pract 1996;46:643–7.PubMed Zermansky A. Who controls repeats? Br J Gen Pract 1996;46:643–7.PubMed
12.
Zurück zum Zitat Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Ann Intern Med 1995;155:1949–56.CrossRef Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Ann Intern Med 1995;155:1949–56.CrossRef
13.
Zurück zum Zitat Van Mil JW, Westerlund TLO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother 2004;38:859–67.PubMedCrossRef Van Mil JW, Westerlund TLO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother 2004;38:859–67.PubMedCrossRef
14.
Zurück zum Zitat Currie JD, Doucette WR, Kuhle J, Sobotka J, Miller WA, McDonough RP, et al. Identification of essential elements in the documentation of pharmacist-provided care. J Am Pharm Assoc 2003;43:41–9.CrossRef Currie JD, Doucette WR, Kuhle J, Sobotka J, Miller WA, McDonough RP, et al. Identification of essential elements in the documentation of pharmacist-provided care. J Am Pharm Assoc 2003;43:41–9.CrossRef
15.
Zurück zum Zitat Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill; 1998. ISBN 0070120463. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill; 1998. ISBN 0070120463.
16.
Zurück zum Zitat Pharmaceutical Care Network Europe. PCNE Classification for drug related problems v5.00. In drug related problems, Pharmaceutical Care Network Europe. http://www.pcne.org/dokumenter/PCNE%20classification%20V5.00.pdf (01 Nov. 2005). Pharmaceutical Care Network Europe. PCNE Classification for drug related problems v5.00. In drug related problems, Pharmaceutical Care Network Europe. http://​www.​pcne.​org/​dokumenter/​PCNE%20classification%20V5.00.pdf (01 Nov. 2005).
17.
Zurück zum Zitat Meyboom RHB, Lindquist M, Egberts ACG. An ABC of drug-related problems. Drug Saf 2000;22:415–23.PubMedCrossRef Meyboom RHB, Lindquist M, Egberts ACG. An ABC of drug-related problems. Drug Saf 2000;22:415–23.PubMedCrossRef
18.
Zurück zum Zitat Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992;45:1045–51.PubMedCrossRef Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992;45:1045–51.PubMedCrossRef
19.
Zurück zum Zitat Van Mil JWF, Tromp ThFJ. Coding frequently asked questions during the pharmaceutical care process with the Pas System. J Appl Ther 1997;1:351–5. Van Mil JWF, Tromp ThFJ. Coding frequently asked questions during the pharmaceutical care process with the Pas System. J Appl Ther 1997;1:351–5.
20.
Zurück zum Zitat Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci 2002;24:120–7.PubMedCrossRef Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci 2002;24:120–7.PubMedCrossRef
21.
Zurück zum Zitat Krska J, Jamieson D, Arris F, McGuire A, Abbott S, Hansford D, et al. A classification system for issues identified in pharmaceutical care practice. Int J Pharm Pract 2002;10:91–100. Krska J, Jamieson D, Arris F, McGuire A, Abbott S, Hansford D, et al. A classification system for issues identified in pharmaceutical care practice. Int J Pharm Pract 2002;10:91–100.
22.
Zurück zum Zitat Llimos F, Faus M. From “drug-related problems" to “negative clinical outcomes". Am J Hosp Pharm 2005;62:2348–50. Llimos F, Faus M. From “drug-related problems" to “negative clinical outcomes". Am J Hosp Pharm 2005;62:2348–50.
23.
Zurück zum Zitat Consensus Committee. Second consensus of granada on drug therapy problems. Ars Pharm 2002;43:179–87. Consensus Committee. Second consensus of granada on drug therapy problems. Ars Pharm 2002;43:179–87.
Metadaten
Titel
Validation of a comprehensive classification tool for treatment-related problems
verfasst von
Salah M. AbuRuz
Nailya R. Bulatova
Almoatasem M. Yousef
Publikationsdatum
01.08.2006
Verlag
Kluwer Academic Publishers
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 4/2006
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-006-9048-0

Weitere Artikel der Ausgabe 4/2006

International Journal of Clinical Pharmacy 4/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.